Clinical Study | Office of Clinical Research

An Open-Label, Non-Randomised, Multicentre Study To Allow Continued Access To And Assess The Safety And Tolerability Of Azd1775 For Patients Enrolled

Posted Date: May 15, 2019

AstraZeneca D6014C00007

To Be Eligible To Participate In This Study, Patients Must Have Advanced Solid Cancer For Which Ther

Cancer, Continued Access, D6014c00007, Phase I, Solid Tumor

Uc Cancer Center
513-584-7698
cancer@uchealth.com

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List